You are here:

Conjugated oestrogen medroxyprogesterone (Premique Low Dose®)

Advice

Following a full submission

Conjugated oestrogen 0.3mg, medroxyprogesterone 1.5mg (Premique Low Dose) is accepted for use within NHS Scotland as hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women with an intact uterus.

It is effective in controlling vasomotor symptoms and is associated with lower rates of breast pain and endometrial bleeding compared to other products with higher oestrogen content. It is more expensive than several other HRT therapies, but less expensive than the current market leader in Scotland.

Drug Details

Drug Name: Conjugated oestrogen medroxyprogesterone (Premique Low Dose®)
SMC Drug ID: 130/04
Manufacturer: Wyeth Pharmaceuticals
Indication: Hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women with an intact uterus
BNF Category:
Sub Category: 6.4 Sex Hormones
Submission Type: Full submission
Status: Accepted
Date Advice Published: 8 November 2004

Back